Costs of intravenous immunoglobulin therapy in patients with unconfirmed parvovirus b19 pure red cell aplasia

Affiliations

¹ Faculty of Medicine, Université Paris Descartes and Department of Internal Medicine, Cochin hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) Commission for the Adequate Prescription of Drugs, AP-HP.
² URC Eco Ile de France, AP-HP.
³ URC Eco Ile de France, AP-HP Université Paris Diderot, Sorbonne Paris Cité, ECEVE, UMRS 1123 Inserm, ECEVE, U1123, Paris, France.
⁴ Commission for the Adequate Prescription of Drugs, AP-HP.

Comment

Luc Mouthon et al. Clin Infect Dis. 2015.

. 2015 Feb 1;60(3):488.

doi: 10.1093/cid/ciu828. Epub 2014 Oct 21.

¹ Faculty of Medicine, Université Paris Descartes and Department of Internal Medicine, Cochin hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) Commission for the Adequate Prescription of Drugs, AP-HP.
² URC Eco Ile de France, AP-HP.
³ URC Eco Ile de France, AP-HP Université Paris Diderot, Sorbonne Paris Cité, ECEVE, UMRS 1123 Inserm, ECEVE, U1123, Paris, France.
⁴ Commission for the Adequate Prescription of Drugs, AP-HP.

No abstract available

Comment on

Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature.
Crabol Y, Terrier B, Rozenberg F, Pestre V, Legendre C, Hermine O, Montagnier-Petrissans C, Guillevin L, Mouthon L; Groupe d'experts de l'Assistance Publique-Hôpitaux de Paris. Crabol Y, et al. Clin Infect Dis. 2013 Apr;56(7):968-77. doi: 10.1093/cid/cis1046. Epub 2012 Dec 12. Clin Infect Dis. 2013. PMID: 23243178 Review.